SCHEMBL8085283

SCHEMBL8085283

C=C(Nc1cccc(N(C)O)c1)c1cccc(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 11/20 0.48
KCNK9 Q9NPC2 8/20 0.48
KCNH2 Q12809 1/20 0.48
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HSP90AA1 P07900 1/20 0.42
HSD17B10 Q99714 1/20 0.41
THRB P10828 1/20 0.40
PKM P14618 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18774009 0.78 KCNK3 (0.51) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL12707417 0.77 MEN1 (0.57) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL22439869 0.77 NPC1 (0.53) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL8086756 0.75 MAPT (0.50) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL13813895 0.74 ACHE (0.50) MEN1KMT2AHSP90AA1CYP1A2CYP3A4
SCHEMBL18773854 0.73 SMN1; SMN2 (0.53) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL18773926 0.73 TP53 (0.49) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL12764313 0.72 KCNK3 (0.80) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL25543568 0.70 KCNK3 (0.47) KCNK3KCNK9KCNH2MEN1KMT2A
SCHEMBL25872256 0.70 ALDH1A1 (0.55) KCNK3KCNK9KCNH2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed